{
    "code": "02021782",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021782",
    "time": "2022-12-09 08:37:10",
    "許可證字號": "衛署藥輸字第021782號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/06\/29",
    "發證日期": "111\/09\/05",
    "許可證種類": "製　劑",
    "舊證字號": "02019333",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202178201",
    "中文品名": "西伯拉丁注射液",
    "英文品名": "CISPLATIN INJECTION &quot;DBL&quot;",
    "適應症": "抗惡性腫瘍劑。",
    "劑型": "270注射劑",
    "包裝": "50、100毫升小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CISPLATIN (CIS-DDPDDP)",
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0031100  HOSPIRA AUSTRALIA PTY LTD.",
            "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012000800",
            "成分名稱": "CISPLATIN (CIS-DDPDDP)",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Cisplatin Injection vial 50 mg in 50 ml 藥物外觀-109-10-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cisplatin injection_Australia 20200406-3-110-07-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=009&Type=9"
        },
        {
            "title": "衛署藥輸字第021782號_西伯拉丁注射液_仿單-109-12-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=008&Type=9"
        },
        {
            "title": "Cisplatin Injection 50 mg in 50 ml carton-109-10-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=007&Type=8"
        },
        {
            "title": "Cisplatin_100mg label-107-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=006&Type=8"
        },
        {
            "title": "Cisplatin_100mg carton-107-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=005&Type=8"
        },
        {
            "title": "Cisplatin_50mg Label-107-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=004&Type=8"
        },
        {
            "title": "Cisplatin_50mg Carton-107-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021782&Seq=003&Type=8"
        }
    ]
}